FDA Warning Letters aren’t just regulatory formalities—they’re red flags signaling oversight gaps that can jeopardize patient safety, trial integrity, and sponsor credibility.
Category: TMF Oversight & Quality
These articles focus on risk-proportionate TMF oversight and the practices that support a complete, accurate, and inspection-ready Trial Master File. Topics include record-level quality, metadata and classification, reconciliation across repositories, and how completeness, quality, and timeliness function as inspection risk signals.
Learnings from the 2025 Veeva R&D Summit
Just in Time GCP Spotlight: Veeva R&D and Quality Summit 2025 The Just in Time GCP team attended the Veeva R&D Quality Summit in Boston, where we proudly served as a Gold Sponsor. The Summit was an exciting experience. It offered a chance to engage with Veeva experts, partners, and users, and to see innovations […]
Trial Master File Health Assessment
Free Tools to Assess eTMF Health Practical, No-Cost Resources for TMF Oversight and Inspection Readiness Your Trial Master File (TMF) is more than a clinical record / document repository—it’s the official story of your study. And under the finalized ICH E6(R3) guideline, it must be managed with risk-proportionate oversight that extends beyond completeness to include […]
Records vs. Documents in Clinical Trials
Records vs. Documentation in Clinical Trials: A Terminology Shift Under ICH E6(R3) In clinical research, precise terminology shapes compliance strategy. One of the most important shifts in the latest ICH E6(R3) Good Clinical Practice (GCP) guideline, finalized in January 2025, is the move from referring to “documents” to using the broader term “records.”As a result, […]
The TMF Reference Model at Small Companies
Just Announced October 13, 2025 – Read More Here Why the TMF Standard Model is Important for Smaller Companies Executing Clinical Trials If you’re a small or emerging life sciences company, navigating the complexities of clinical trials can be daunting. A key element to understand is the Trial Master File (TMF)—a collection of essential records […]
Hidden TMF Clinical Compliance Risks
Hidden TMF Clinical Compliance Risks The Risk Of Inspectable Content Housed Outside the TMF In the fast-paced world of clinical trial compliance, maintaining a robust and compliant Trial Master File (TMF) is essential for inspection readiness clinical trials. Yet, many sponsors inadvertently overlook critical good clinical practice (GCP) documentation. This oversight can create unnecessary stress […]
TMF Trends from 2024
Clinical Trial Master File Trends from 2024 As we approach 2025, the Clinical Trial Master File (TMF) landscape is undergoing substantial transformations. These are being driven by technological advancements and evolving regulatory requirements. At Just in Time GCP, we work with TMFs of all shapes and sizes, and this year, we have identified several clear […]
TMF Management in Clinical Trials
TMF Management in Clinical Trials: Ensuring Quality, Compliance, and Oversight Just in Time GCP’s Founder and CEO, Donna Dorozinsky, shared her insights in The Clinical Trial Vanguard article titled The Trial Master File: A Window into the Quality of Any Clinical Study. The article underscores the TMF’s essential role in maintaining compliance, oversight, and data […]